Dual targeted therapy with pyrotinib and trastuzumab for<scp>HER2</scp>‐positive advanced colorectal cancer: A phase 2 trial
Xianhua Fu(Zhejiang University), Ying Yuan(Zhejiang Cancer Hospital), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Weidong Han(Zhejiang Cancer Hospital), Yang Liu(Fudan University), Hanguang Hu(Zhejiang University), Suzhan Zhang(Zhejiang Cancer Hospital), Weijia Fang(Zhejiang Cancer Hospital)
Cited by 29
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b
|Journal of Translational Medicine|2015|660
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
New development in CAR-T cell therapy
|Journal of Hematology & Oncology|2017|409